Al Onazi Mona M, Campbell Kristin L, Mackey John R, McNeely Margaret L
From the: Department of Physical Therapy, University of Alberta, Edmonton, Alberta, Canada.
Department of Physical Therapy, University of British Columbia, Vancouver, British Columbia, Canada.
Physiother Can. 2024 Aug;76(3):307-319. doi: 10.3138/ptc-2022-0009. Epub 2023 Mar 21.
This systematic review aimed to examine the benefit of combined upper body exercise and compression therapy for breast cancer related lymphedema.
Electronic searches were performed in Medline, EMBASE, CINAHL, SPORTDiscus, and PEDRO. We included randomized and controlled clinical trials that examined the effect of upper body exercise with use of compression therapy on arm lymphedema. Where data were available, effect sizes were calculated. Risk of bias was assessed using the Cochrane risk-of-bias tool. The quality of evidence was rated using Grading of Recommendations Assessment, Development and Evaluation (GRADE).
Of 444 studies, 11 met all inclusion criteria. Two cross-over trials examined single bouts of upper body exercise with or without compression, three intervention trials examined non-resisted upper body exercise and compression, and six intervention trials examined upper body resistance exercise and compression. Only two studies reported statistically significant benefit from the combined intervention for arm lymphedema volume. Seven studies provided adequate data to allow for calculation of effect size; however, heterogeneity precluded pooling of data. The quality of evidence was moderate in intervention trials comparing combined upper body exercise and compression to standard care ( = 1) or to exercise alone ( = 1). For all other trials the grade of evidence was low, with quality ratings downgraded due to small sample sizes and/or high or unclear risk of bias.
No clear conclusions could be made regarding the benefit of combined upper body exercise and compression for breast cancer related lymphedema. Further high-quality trials are warranted.
本系统评价旨在探讨上肢运动与压迫疗法联合应用对乳腺癌相关淋巴水肿的益处。
在Medline、EMBASE、CINAHL、SPORTDiscus和PEDRO数据库中进行电子检索。我们纳入了随机对照临床试验,这些试验研究了上肢运动联合压迫疗法对上肢淋巴水肿的影响。如有可用数据,则计算效应量。使用Cochrane偏倚风险工具评估偏倚风险。采用推荐分级的评估、制定与评价(GRADE)对证据质量进行评级。
在444项研究中,11项符合所有纳入标准。两项交叉试验研究了单次上肢运动(有或无压迫),三项干预试验研究了非抗阻上肢运动与压迫,六项干预试验研究了上肢抗阻运动与压迫。只有两项研究报告联合干预对上肢淋巴水肿体积有统计学意义的益处。七项研究提供了足够的数据以计算效应量;然而,异质性妨碍了数据合并。在将上肢运动与压迫联合应用与标准护理(n = 1)或单独运动(n = 1)进行比较的干预试验中,证据质量为中等。对于所有其他试验,证据等级较低,由于样本量小和/或偏倚风险高或不明确,质量评级被下调。
关于上肢运动与压迫联合应用对乳腺癌相关淋巴水肿的益处,无法得出明确结论。需要进一步开展高质量试验。